You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)

Article metrics

Article menu
Download PDFPDF
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)

 

Online download statistics by month:

Online download statistics by month: April 2016 to March 2024

AbstractFullPdf
Apr 2016202
Jun 2016101
Sep 2016001
Nov 2016404
Jan 2017601
Feb 2017400
Mar 2017301
Apr 2017200
May 2017100
Jun 2017300
Jul 2017200
Aug 20171200
Dec 2017501
Jan 2018400
Feb 2018600
Mar 20181500
Apr 2018700
May 2018400
Jul 2018600
Aug 20181200
Oct 2018401
Nov 2018200
Dec 2018600
Jan 2019200
Feb 2019600
Mar 2019200
Apr 2019200
May 2019801
Jun 2019800
Jul 2019800
Aug 2019401
Dec 2019400
Apr 2020200
May 2020200
Jun 2020400
Jul 2020400
Aug 2020201
Sep 20201200
Oct 2020600
Jan 20211405
Feb 2021402
Mar 2021401
Apr 2021601
May 2021101
Jun 2021001
Jul 2021102
Aug 2021004
Sep 2021006
Oct 20216015
Nov 2021207
Dec 2021002
Jan 2022200
Feb 20221001
Mar 2022002
Apr 2022400
May 2022607
Jun 2022502
Jul 2022402
Aug 20221202
Sep 2022407
Oct 2022404
Nov 2022400
Dec 20221202
Jan 2023403
Feb 2023200
Mar 2023600
May 2023401
Jul 2023803
Aug 2023003
Sep 2023002
Oct 2023200
Nov 2023101
Dec 20231600
Jan 20241200
Feb 2024400
Mar 20241800
Total3690104